Hershberg Robert is a director of Fate Therapeutics Inc.
Person profile
Roles
Address
Seattle, Washington
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
RECURSION PHARMACEUTICALS, INC.
5 Jun 24
4
Adaptive Biotechnologies Corp
6 Mar 24
4
HilleVax, Inc.
12 Feb 24
144
HilleVax, Inc.
22 Jan 24
4
RECURSION PHARMACEUTICALS, INC.
21 Jun 23
4
FATE THERAPEUTICS INC
7 Jun 23
4
Adaptive Biotechnologies Corp
8 Mar 23
4
Adaptive Biotechnologies Corp
3 Feb 23
4
HilleVax, Inc.
3 Feb 23
4
RECURSION PHARMACEUTICALS, INC.
16 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jun 24 | RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | Class A Common Stock | Grant | Acquire A | No | No | 0 | 13,097 | 0.00 | 51,716 |
3 Jun 24 | RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 8.59 | 26,193 | 225.00 k | 26,193 |
4 Mar 24 | ADPT Adaptive Biotechnologies | Common Stock | Grant | Acquire A | No | No | 0 | 31,328 | 0.00 | 107,296 |
4 Mar 24 | ADPT Adaptive Biotechnologies | Stock Option Common Stock | Grant | Acquire A | No | No | 3.99 | 48,044 | 191.70 k | 48,044 |
8 Feb 24 | HLVX HilleVax | Common Stock | Grant | Acquire A | No | No | 0 | 174,202 | 0.00 | 1,128,033 |
8 Feb 24 | HLVX HilleVax | Common Stock | Sell | Dispose S | No | No | 14.9315 | 11,597 | 173.16 k | 953,831 |
8 Feb 24 | HLVX HilleVax | Stock Option Common Stock | Grant | Acquire A | No | No | 15.06 | 226,885 | 3.42 mm | 226,885 |
16 Jun 23 | RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | Class A Common Stock | Grant | Acquire A | No | No | 0 | 12,612 | 0.00 | 38,619 |
16 Jun 23 | RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 8.92 | 25,224 | 225.00 k | 25,224 |
6 Jun 23 | FATE Fate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.52 | 40,000 | 220.80 k | 40,000 |